Recent Quarter Total Invested
$129.22 M
Recent Quarter Institutional Ownership Percentage
44.78%
Total Invested of Last Quarter
$162.15 M
Ownership Percentage of Last Quarter
56.68%
Prelude Therapeutics Incorporated Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 08/14/2024 | 10.91 M | $41.56 M | 0.00% | 14.40% |
| BAKER BROS. ADVISORS LP | 08/14/2024 | 10.12 M | $38.57 M | 0.00% | 13.37% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 08/14/2024 | 4.13 M | $15.75 M | 0.00% | 5.46% |
| BOXER CAPITAL, LLC | 08/14/2024 | 2.57 M | $9.79 M | 0.00% | 3.39% |
| BLACKROCK INC. | 08/13/2024 | 1.07 M | $4.07 M | -2.60% | 1.41% |
| VANGUARD GROUP INC | 08/13/2024 | 1.01 M | $3.85 M | -0.63% | 1.33% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 08/14/2024 | 891,298 | $3.40 M | -5.38% | 1.18% |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 08/09/2024 | 522,375 | $1.99 M | 2.80% | 0.69% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 361,951 | $1.38 M | 0.09% | 0.48% |
| SIO CAPITAL MANAGEMENT, LLC | 08/14/2024 | 320,394 | $1.22 M | 0.00% | 0.42% |
| MORGAN STANLEY | 10/17/2024 | 287,354 | $1.09 M | -2.99% | 0.38% |
| STATE STREET CORP | 08/14/2024 | 211,746 | $806,752 | 0.14% | 0.28% |
| RENAISSANCE TECHNOLOGIES LLC | 08/09/2024 | 206,600 | $787,146 | -15.60% | 0.27% |
| TD ASSET MANAGEMENT INC | 08/02/2024 | 160,652 | $612,084 | 0.00% | 0.21% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/12/2024 | 128,033 | $487,806 | 0.52% | 0.17% |
| NORTHERN TRUST CORP | 08/14/2024 | 124,686 | $475,053 | 2.08% | 0.16% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 08/14/2024 | 123,600 | $470,916 | 0.00% | 0.16% |
| GOLDMAN SACHS GROUP INC | 08/13/2024 | 74,923 | $285,457 | 11.12% | 0.10% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 08/14/2024 | 70,045 | $266,871 | -3.07% | 0.09% |
| TWO SIGMA ADVISERS, LP | 08/14/2024 | 50,900 | $193,929 | -27.49% | 0.07% |
| EXCHANGE TRADED CONCEPTS, LLC | 08/13/2024 | 48,727 | $185,650 | -23.73% | 0.06% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2024 | 43,135 | $164,344 | -28.82% | 0.06% |
| BANK OF NEW YORK MELLON CORP | 07/25/2024 | 36,276 | $138,212 | -9.46% | 0.05% |
| KENNEDY CAPITAL MANAGEMENT LLC | 08/14/2024 | 35,283 | $134,428 | 40.93% | 0.05% |
| BANK OF AMERICA CORP /DE/ | 08/14/2024 | 34,278 | $130,599 | 6.24% | 0.05% |
| CITADEL ADVISORS LLC | 08/14/2024 | 31,388 | $119,588 | 5.35% | 0.04% |
| DIMENSIONAL FUND ADVISORS LP | 08/09/2024 | 29,074 | $110,608 | 103.24% | 0.04% |
| HSBC HOLDINGS PLC | 08/12/2024 | 24,905 | $90,654 | 0.00% | 0.03% |
| ACADIAN ASSET MANAGEMENT LLC | 08/06/2024 | 22,110 | $83,000 | 0.00% | 0.03% |
| RHUMBLINE ADVISERS | 08/01/2024 | 21,565 | $82,155 | 1.89% | 0.03% |
| NEW YORK STATE COMMON RETIREMENT FUND | 07/31/2024 | 19,122 | $73,000 | -4.97% | 0.03% |
| Y-INTERCEPT (HONG KONG) LTD | 08/14/2024 | 18,839 | $71,777 | 100.00% | 0.02% |
| STATE OF WISCONSIN INVESTMENT BOARD | 08/14/2024 | 18,700 | $71,247 | -4.59% | 0.02% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 08/14/2024 | 17,761 | $67,669 | 100.00% | 0.02% |
| NUVEEN ASSET MANAGEMENT, LLC | 08/09/2024 | 16,797 | $63,997 | 0.00% | 0.02% |
| WALLEYE CAPITAL LLC | 08/14/2024 | 15,229 | $58,022 | -7.03% | 0.02% |
| DEUTSCHE BANK AG\ | 08/14/2024 | 14,618 | $55,695 | 100.00% | 0.02% |
| BARCLAYS PLC | 08/14/2024 | 14,601 | $56,000 | -28.38% | 0.02% |
| JANE STREET GROUP, LLC | 08/15/2024 | 12,948 | $49,332 | -20.99% | 0.02% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 08/09/2024 | 12,345 | $47,034 | -38.48% | 0.02% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 08/14/2024 | 11,074 | $42,192 | -20.02% | 0.01% |
| UBS GROUP AG | 08/14/2024 | 10,934 | $41,659 | -30.16% | 0.01% |
| FMR LLC | 08/13/2024 | 9,575 | $36,481 | -17.10% | 0.01% |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 08/14/2024 | 8,135 | $30,994 | 100.00% | 0.01% |
| COREBRIDGE FINANCIAL, INC. | 08/14/2024 | 7,092 | $27,021 | 100.00% | 0.01% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 08/13/2024 | 7,064 | $26,914 | 111.05% | 0.01% |
| JPMORGAN CHASE & CO | 08/12/2024 | 5,860 | $22,327 | -6.20% | 0.01% |
| WELLS FARGO & COMPANY/MN | 08/13/2024 | 5,792 | $22,068 | 9.82% | 0.01% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 08/14/2024 | 3,126 | $11,910 | 100.00% | 0.00% |
| CITIGROUP INC | 08/12/2024 | 3,014 | $11,484 | 7.30% | 0.00% |
Prelude Therapeutics Incorporatedinstitutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of PRLD shares?
During the previous two years, 72 institutional investors and hedge funds held shares of Prelude Therapeutics Incorporated. The most heavily invested institutionals were:
ORBIMED ADVISORS LLC: 10.91 M
BAKER BROS. ADVISORS LP: 10.12 M
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C): 3.77 M
Boxer Capital, LLC: 1.71 M
PRICE T ROWE ASSOCIATES INC /MD/: 1.1 M
BlackRock Funding, Inc. /DE: 1.06 M
-
What percentage of Prelude Therapeutics Incorporated stock is owned by institutional investors?
44.78% of Prelude Therapeutics Incorporated stock is owned by institutional investors.
-
How much institutional buying is happening at PRLD ?
Institutional investors have bought a total of 35.69 M shares in the last 24 months. This purchase volume represents approximately $33.90 M in transactions.